Stay updated with breaking news from Joshua Hare. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Longeveron (NASDAQ:LGVN – Get Free Report) had its price objective boosted by stock analysts at HC Wainwright from $6.00 to $12.00 in a note issued to investors on Monday, Benzinga reports. The firm presently has a “buy” rating on the stock. Longeveron Price Performance NASDAQ LGVN traded down $0.06 during trading hours on Monday, reaching […]
Advancements in the use of stem cell therapies in medicine are moving at a rapid pace.
Jackson Health System has hired a new chief to oversee its heart transplant program, which has been shut down since March.
Longeveron (NASDAQ: LGVN) announced the results of its phase 1 trial for infants with a rare and serious congenital heart disease (CHD), known as hypoplastic left heart syndrome.
Operator: Good morning, and welcome to Longeveron's call today to discuss the company's 2023 First Quarter and Financial Results. All participants are currently in listen-only mode.